Published in J Invest Dermatol on March 15, 2007
A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem (2010) 1.08
Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol (2010) 0.93
Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol (2010) 0.90
Mannose-binding lectin and the balance between immune protection and complication. Expert Rev Anti Infect Ther (2011) 0.89
Mannose-binding lectin binds to amyloid β protein and modulates inflammation. J Biomed Biotechnol (2012) 0.82
Murine hyperglycemic vasculopathy and cardiomyopathy: whole-genome gene expression analysis predicts cellular targets and regulatory networks influenced by mannose binding lectin. Front Immunol (2012) 0.81
Molecular defects in the mannose binding lectin pathway in dermatological disease: Case report and literature review. Clin Mol Allergy (2010) 0.79
Topical application effect of the isolectin hydrogel (Cramoll 1,4) on second-degree burns: experimental model. J Biomed Biotechnol (2012) 0.78
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood (2002) 3.58
The human mannose-binding protein functions as an opsonin. J Exp Med (1989) 3.15
Molecular basis of opsonic defect in immunodeficient children. Lancet (1991) 3.00
Burn wound infections: current status. World J Surg (1998) 2.86
Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today (1994) 2.81
Serum lectin with known structure activates complement through the classical pathway. J Biol Chem (1987) 2.79
Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med (1992) 2.76
Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol (2002) 2.51
Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med (2004) 2.12
Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol (2005) 2.02
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol (2005) 1.89
Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci (1999) 1.81
The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci U S A (2005) 1.71
Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol (2005) 1.69
Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet (1992) 1.66
Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg (2000) 1.51
The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol (2005) 1.46
Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol (2005) 1.44
Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol (2000) 1.43
The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc (2002) 1.41
Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J Immunol (2005) 1.37
Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35
Structural analysis of monosaccharide recognition by rat liver mannose-binding protein. J Biol Chem (1996) 1.28
Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect (2002) 1.26
Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J Invest Dermatol (2004) 1.23
Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today (1994) 1.21
Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol (2002) 1.17
L-MBP is expressed in epithelial cells of mouse small intestine. J Immunol (2002) 1.13
Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol (2006) 1.11
Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect Immun (2004) 1.10
A study of cytokines in burn blister fluid related to wound healing. Burns (1995) 1.08
Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol (1993) 1.08
MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc Res (2002) 1.07
Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol (1994) 1.05
IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med (2002) 1.03
Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand J Immunol (1999) 1.02
Early inflammatory cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res (1999) 1.01
Pathophysiologic events related to thermal injury of skin. J Trauma (1990) 1.00
Role of leukocyte adhesion molecules in lung and dermal vascular injury after thermal trauma of skin. Am J Pathol (1994) 0.99
Interaction of mannose-binding protein with associated serine proteases: effects of naturally occurring mutations. J Biol Chem (2000) 0.98
Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism. Exp Clin Immunogenet (1992) 0.98
Immunological responses to thermal injury. Burns (1997) 0.97
Microvascular permeability to macromolecules in thermal injury. Acta Physiol Scand Suppl (1979) 0.95
Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann Surg (2000) 0.94
Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children. Ann Surg (2000) 0.93
Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res (1997) 0.92
Extrahepatic synthesis of complement proteins in inflammation. Mol Immunol (2001) 0.92
The role of matrix metalloproteinase 7 in innate immunity. Immunobiology (2004) 0.91
Effect of chronic wound exudates and MMP-2/-9 inhibitor on angiogenesis in vitro. Plast Reconstr Surg (2005) 0.91
Burning the largest immune organ. Burns (1995) 0.89
Thermal injury-induced peroxynitrite production and pulmonary inducible nitric oxide synthase expression depend on JNK/AP-1 signaling. Crit Care Med (2006) 0.89
Localization of mRNAs representing interstitial collagenase, 72-kda gelatinase, and TIMP in healing porcine burn wounds. J Invest Dermatol (1994) 0.88
Matrix metalloproteinases and their tissue inhibitors in severely burned children. Wound Repair Regen (2003) 0.88
Monocyte chemoattractant protein-1 (MCP-1) and macrophage infiltration into the skin after burn injury in aged mice. Burns (2003) 0.86
Requirement for C5a in lung vascular injury following thermal trauma to rat skin. Shock (1997) 0.86
Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burn-associated type 2 T-cell responses. Ann Surg (2002) 0.86
C1 inhibitor prevents capillary leakage after thermal trauma. Crit Care Med (2000) 0.85
TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg (2003) 0.85
The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc Endovasc Surg (2006) 0.85
Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta. J Immunol (2005) 0.84
Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement. Fundam Clin Pharmacol (2001) 0.84
The Gly-54-->Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine protease. Biochem J (1995) 0.84
Role of anti-L-selectin antibody in burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol (2002) 0.82
Primary excision and immediate wound closure. Intensive Care Med (1981) 0.81
Regulation of the insulin-like growth factor system by insulin in burn patients. J Clin Endocrinol Metab (1996) 0.81
Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit Care Med (1996) 0.80
Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver. Mol Ther (2001) 0.80
Ultraviolet-B recruits mannose-binding lectin into skin from non-cutaneous sources. J Invest Dermatol (2005) 0.80
Regulation of elastase-type endopeptidase activity, MMP-2 and MMP-9 expression and activation in human dermal fibroblasts by fucose and a fucose-rich polysaccharide. Biomed Pharmacother (2002) 0.77
Ulex europaeus I lectin induces activation of matrix-metalloproteinase-2 in endothelial cells. Biochem Biophys Res Commun (1995) 0.76
Inflammatory proteins: chemical and biological aspects. Clin Biochem (1980) 0.76
Expression and regulation of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells induced by sera from severely burned patients. Crit Care Med (2004) 0.75
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol (2007) 6.69
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer (2006) 3.93
Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol (2012) 3.86
Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol (2001) 2.90
Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol (2005) 2.89
Biphasic dose response in low level light therapy. Dose Response (2009) 2.78
The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng (2011) 2.37
Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med (2004) 2.12
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med (2009) 2.10
Mannose-binding lectin and innate immunity. Immunol Rev (2009) 2.08
Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol (2005) 2.02
4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential. JACC Cardiovasc Imaging (2012) 1.94
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab (2003) 1.93
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol (2005) 1.89
Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother (2005) 1.89
Role of low-level laser therapy in neurorehabilitation. PM R (2010) 1.79
Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol (2006) 1.78
Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One (2011) 1.76
Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther (2009) 1.73
L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem (2004) 1.70
Biphasic dose response in low level light therapy - an update. Dose Response (2011) 1.69
Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest (2006) 1.69
Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol (2005) 1.69
Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med (2008) 1.64
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun (2005) 1.64
In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat Genet (2006) 1.61
Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes (2004) 1.59
Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother (2006) 1.58
Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci (2004) 1.57
Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. J Leukoc Biol (2011) 1.55
An efficient system to establish multiple embryonic stem cell lines carrying an inducible expression unit. Nucleic Acids Res (2005) 1.55
Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods (2003) 1.54
Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med (2003) 1.52
Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials (2006) 1.51
Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother (2009) 1.50
Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B (2005) 1.50
Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players. Lasers Med Sci (2015) 1.46
Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod (2007) 1.46
Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) (2011) 1.45
Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med (2010) 1.45
Can surgical site infections be treated by photodynamic therapy? Photodiagnosis Photodyn Ther (2010) 1.43
Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat (2012) 1.42
Photodynamic therapy for infections: clinical applications. Lasers Surg Med (2011) 1.42
Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol (2009) 1.39
Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J Immunol (2007) 1.39
Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg (2010) 1.38
Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J Immunol (2010) 1.38
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic Biol Med (2007) 1.37
Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time. Lasers Surg Med (2007) 1.36
Low-level light stimulates excisional wound healing in mice. Lasers Surg Med (2007) 1.36
Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct (2009) 1.35
Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg (2013) 1.34
Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med (2007) 1.33
Photodynamic therapy with fullerenes. Photochem Photobiol Sci (2007) 1.32
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology (2006) 1.30
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol (2005) 1.28
Mannan-binding lectin--a soluble pattern recognition molecule. Mol Immunol (2004) 1.28
The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog (2012) 1.28
MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J Immunol (2009) 1.26
Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect (2002) 1.26
Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol (2011) 1.25
Disease-causing mutations in genes of the complement system. Am J Hum Genet (2011) 1.24
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A (2008) 1.23
Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev Anti Infect Ther (2011) 1.23
Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol (2009) 1.22
Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother (2006) 1.22
Effect of pulsing in low-level light therapy. Lasers Surg Med (2010) 1.21
Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One (2011) 1.21
C-reactive protein collaborates with plasma lectins to boost immune response against bacteria. EMBO J (2007) 1.19
Shock wave-mediated molecular delivery into cells. Biochim Biophys Acta (2002) 1.19
Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun (2009) 1.19
Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab (2003) 1.18
The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. J Immunol (2006) 1.17
Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol (2005) 1.17
Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med (2005) 1.15
Comparison of therapeutic effects between pulsed and continuous wave 810-nm wavelength laser irradiation for traumatic brain injury in mice. PLoS One (2011) 1.15
Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers Surg Med (2012) 1.15
B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol (2010) 1.14
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res (2009) 1.14
L-MBP is expressed in epithelial cells of mouse small intestine. J Immunol (2002) 1.13
Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev (2013) 1.13
Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med (2010) 1.12
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One (2010) 1.12
Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One (2012) 1.12
Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice. Wound Repair Regen (2008) 1.11
Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11
Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria. Lasers Surg Med (2012) 1.11
Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol (2010) 1.11
Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol (2006) 1.11